GEHC Relative Valuation
GEHC's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, GEHC is overvalued; if below, it's undervalued.
Historical Valuation
GE Healthcare Technologies Inc (GEHC) is now in the Undervalued zone, suggesting that its current forward PE ratio of 14.68 is considered Undervalued compared with the five-year average of 18.26. The fair price of GE Healthcare Technologies Inc (GEHC) is between 89.21 to 103.02 according to relative valuation methord. Compared to the current price of 70.63 USD , GE Healthcare Technologies Inc is Undervalued By 20.83%.
Relative Value
Fair Zone
89.21-103.02
Current Price：70.63
20.83%
Undervalued
14.68
PE
1Y
3Y
5Y
Trailing
Forward
10.58
EV/EBITDA
GE Healthcare Technologies Inc. (GEHC) has a current EV/EBITDA of 10.58. The 5-year average EV/EBITDA is 11.47. The thresholds are as follows: Strongly Undervalued below 8.25, Undervalued between 8.25 and 9.86, Fairly Valued between 13.08 and 9.86, Overvalued between 13.08 and 14.69, and Strongly Overvalued above 14.69. The current Forward EV/EBITDA of 10.58 falls within the Historic Trend Line -Fairly Valued range.
12.24
EV/EBIT
GE Healthcare Technologies Inc. (GEHC) has a current EV/EBIT of 12.24. The 5-year average EV/EBIT is 13.58. The thresholds are as follows: Strongly Undervalued below 9.71, Undervalued between 9.71 and 11.64, Fairly Valued between 15.51 and 11.64, Overvalued between 15.51 and 17.44, and Strongly Overvalued above 17.44. The current Forward EV/EBIT of 12.24 falls within the Historic Trend Line -Fairly Valued range.
70.63
PS
GE Healthcare Technologies Inc. (GEHC) has a current PS of 70.63. The 5-year average PS is 3.18. The thresholds are as follows: Strongly Undervalued below -17.04, Undervalued between -17.04 and -6.93, Fairly Valued between 13.28 and -6.93, Overvalued between 13.28 and 23.39, and Strongly Overvalued above 23.39. The current Forward PS of 70.63 falls within the Strongly Overvalued range.
12.77
P/OCF
GE Healthcare Technologies Inc. (GEHC) has a current P/OCF of 12.77. The 5-year average P/OCF is 14.97. The thresholds are as follows: Strongly Undervalued below 10.16, Undervalued between 10.16 and 12.56, Fairly Valued between 17.37 and 12.56, Overvalued between 17.37 and 19.77, and Strongly Overvalued above 19.77. The current Forward P/OCF of 12.77 falls within the Historic Trend Line -Fairly Valued range.
20.32
P/FCF
GE Healthcare Technologies Inc. (GEHC) has a current P/FCF of 20.32. The 5-year average P/FCF is 19.51. The thresholds are as follows: Strongly Undervalued below 11.95, Undervalued between 11.95 and 15.73, Fairly Valued between 23.29 and 15.73, Overvalued between 23.29 and 27.07, and Strongly Overvalued above 27.07. The current Forward P/FCF of 20.32 falls within the Historic Trend Line -Fairly Valued range.
GE Healthcare Technologies Inc (GEHC) has a current Price-to-Book (P/B) ratio of 3.22. Compared to its 3-year average P/B ratio of 4.12 , the current P/B ratio is approximately -21.88% higher. Relative to its 5-year average P/B ratio of 4.12, the current P/B ratio is about -21.88% higher. GE Healthcare Technologies Inc (GEHC) has a Forward Free Cash Flow (FCF) yield of approximately 0.04%. Compared to its 3-year average FCF yield of 162610.88%, the current FCF yield is approximately -100.00% lower. Relative to its 5-year average FCF yield of 162610.88% , the current FCF yield is about -100.00% lower.
3.22
P/B
Median3y
4.12
Median5y
4.12
0.04
FCF Yield
Median3y
162610.88
Median5y
162610.88
Competitors Valuation Multiple
The average P/S ratio for GEHC's competitors is 366.33, providing a benchmark for relative valuation. GE Healthcare Technologies Inc Corp (GEHC) exhibits a P/S ratio of 70.63, which is -80.72% above the industry average. Given its robust revenue growth of 5.76%, this premium appears unsustainable.
P/S
P/E
EV/EBITDA
EV/EBIT
P/S
Revenue Growth
Market Cap
Performance Decomposition
1Y
3Y
5Y
Market capitalization of GEHC decreased by 15.13% over the past 1 year. The primary factor behind the change was an increase in Revenue Growth from 4.86B to 5.14B.
The secondary factor is the Margin Expansion, contributed -10.34%to the performance.
Overall, the performance of GEHC in the past 1 year is driven by Revenue Growth. Which is more sustainable.
People Also Watch
FAQ
Is GE Healthcare Technologies Inc (GEHC) currently overvalued or undervalued?
What is GE Healthcare Technologies Inc (GEHC) fair value?
How does GEHC's valuation metrics compare to the industry average?
What is the current P/B ratio for GE Healthcare Technologies Inc (GEHC) as of Nov 19 2025?
What is the current FCF Yield for GE Healthcare Technologies Inc (GEHC) as of Nov 19 2025?
What is the current Forward P/E ratio for GE Healthcare Technologies Inc (GEHC) as of Nov 19 2025?